Published in Anat Rec (Hoboken) on September 08, 2011
Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation (2012) 1.04
PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders. PLoS One (2013) 0.97
Evidence for dysregulation of axonal growth and guidance in the etiology of ASD. Front Hum Neurosci (2013) 0.95
Neonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult rats. Front Cell Neurosci (2013) 0.86
Neurobiological abnormalities in the first few years of life in individuals later diagnosed with autism spectrum disorder: a review of recent data. Behav Neurol (2014) 0.80
The neuropathology of autism. Scientifica (Cairo) (2012) 0.79
Olfactory processing in adults with autism spectrum disorders. Mol Autism (2016) 0.79
Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum. J Autism Dev Disord (2016) 0.77
Parkinson's disease. Lancet (2009) 6.60
Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95
Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology (2001) 5.92
Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry (2008) 5.83
Neuroanatomy of autism. Trends Neurosci (2008) 5.59
Evidence of brain overgrowth in the first year of life in autism. JAMA (2003) 5.47
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol (2005) 4.96
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
A clinicopathological study of autism. Brain (1998) 3.49
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry (2009) 3.32
The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci (2004) 3.30
Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci (2005) 3.01
Neurobiology of aggression and violence. Am J Psychiatry (2008) 2.78
Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry (1998) 2.69
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol (2009) 2.60
Neuropathological findings in autism. Brain (2004) 2.34
Mechanisms of tau-induced neurodegeneration. Acta Neuropathol (2009) 2.27
The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci (2008) 2.26
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res (2006) 2.11
The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain (2002) 2.05
Neuropathology of infantile autism. J Neuropathol Exp Neurol (1998) 2.04
Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol (1999) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology (2006) 1.83
Stereological analysis of amygdala neuron number in autism. J Neurosci (2006) 1.75
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr (2000) 1.67
Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol (1976) 1.61
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57
Neuropathology of Alzheimer's disease. Mt Sinai J Med (2010) 1.57
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr (1961) 1.56
Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Dev Psychopathol (2005) 1.55
Neurons in the fusiform gyrus are fewer and smaller in autism. Brain (2008) 1.50
Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics (1997) 1.50
Neurobiological mechanisms in major depressive disorder. CMAJ (2009) 1.49
Serotonin and epilepsy. J Neurochem (2007) 1.49
Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study. J Comp Neurol (1976) 1.49
Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci (2008) 1.48
Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res (2008) 1.46
Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci (2005) 1.42
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Autism spectrum disorders: concurrent clinical disorders. J Child Neurol (2007) 1.40
Sensory processing in adults with autism spectrum disorders. Autism (2009) 1.39
Serotonin and brain development: role in human developmental diseases. Brain Res Bull (2001) 1.39
Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil (2005) 1.38
Diagnostic validity of sensory over-responsivity: a review of the literature and case reports. J Autism Dev Disord (2007) 1.38
Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc Natl Acad Sci U S A (1987) 1.38
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol (1990) 1.37
Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry (1987) 1.35
The neuropathology of autism: a review. J Neuropathol Exp Neurol (2005) 1.34
Lewy body pathology in Alzheimer's disease. J Mol Neurosci (2001) 1.34
Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol (1997) 1.33
Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci (2005) 1.31
The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse (1987) 1.31
Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res (2005) 1.30
Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res (1992) 1.29
Hippocampus in autism: a Golgi analysis. Acta Neuropathol (1996) 1.29
Dendritic differentiation in human cerebral cortex: normal and aberrant developmental patterns. Adv Neurol (1975) 1.28
The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol (1986) 1.26
Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci (2005) 1.26
Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl (1990) 1.25
Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.23
White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry (2005) 1.23
Cerebral dominance for language function in adults with specific language impairment or autism. Brain (2008) 1.20
Auditory discrimination and auditory sensory behaviours in autism spectrum disorders. Neuropsychologia (2009) 1.19
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res (1998) 1.19
Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.17
Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther (1987) 1.16
Dendritic atrophy in children with Down's syndrome. Ann Neurol (1986) 1.16
Modeling early cortical serotonergic deficits in autism. Behav Brain Res (2006) 1.14
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur J Neurol (2007) 1.14
Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci (1990) 1.12
Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet (2006) 1.10
Risk factors for self-injurious behaviours among 222 young children with autistic disorders. J Intellect Disabil Res (2003) 1.10
Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol (2005) 1.10
Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci U S A (2005) 1.08
Moderate alcohol exposure compromises neural tube midline development in prenatal brain. Brain Res Dev Brain Res (2003) 1.05
Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation. J Child Adolesc Psychopharmacol (1997) 1.01
Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology (1999) 1.01
Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience (2002) 1.00
Transient microcircuits formed by subplate neurons and their role in functional development of thalamocortical connections. Neuroreport (2004) 1.00
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today (2008) 1.00
Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates. Am J Psychiatry (1995) 0.98
Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord (2006) 0.97
Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism. J Neurochem (2006) 0.96
[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord (2001) 0.96
Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res (2007) 0.94
Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry (1977) 0.92
Relationship between whole blood serotonin and repetitive behaviors in autism. Psychiatry Res (2009) 0.91
The enteric nervous system II: gastrointestinal functions. Pharmacol Toxicol (2003) 0.90
Dystrophic serotonergic axons in neurodegenerative diseases. Brain Res (2008) 0.90
Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res (1992) 0.90
Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc (1992) 0.88
Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.87
Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord (2008) 0.87
Effects of ethanol and 5-HT1A agonists on astroglial S100B. Brain Res Dev Brain Res (2002) 0.85
Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram. Neuroscience (1993) 0.83
Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology (2004) 0.83
Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat. J Comp Neurol (2001) 0.82
Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol (2005) 6.16
Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63
Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging (2004) 2.18
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett (2006) 1.48
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J (2008) 1.43
Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem (2011) 1.24
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J Biol Chem (2008) 1.22
Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr (2007) 1.15
Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). Arch Biochem Biophys (2010) 1.00
Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J Neurochem (2004) 0.97
Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry (2006) 0.95
Humoral immune response to fibrillar beta-amyloid peptide. Biochemistry (2003) 0.93
Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome. J Alzheimers Dis (2008) 0.90
Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun (2014) 0.90
Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. J Neurosci Res (2012) 0.89
Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology (2011) 0.88
Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults. Acta Neuropathol Commun (2015) 0.87
Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. Brain Res (2005) 0.86
Alzheimer's Disease in Adults with Down Syndrome. Int Rev Res Ment Retard (2008) 0.86
Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors. Mol Cell Endocrinol (2005) 0.85
Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection. Acta Neuropathol (2013) 0.84
A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. J Alzheimers Dis (2004) 0.83
Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients. J Neuropathol Exp Neurol (2012) 0.81
Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects. J Alzheimers Dis (2010) 0.80
The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism. Acta Neuropathol Commun (2013) 0.80
Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease. J Alzheimers Dis (2009) 0.80
An entorhinal cortex sulcal pattern is associated with Alzheimer's disease. Hum Brain Mapp (2009) 0.78
Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). J Neurosci Res (2013) 0.77
Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Curr Alzheimer Res (2004) 0.77
Activity-dependent phosphorylation of dynamin 1 at serine 857. Biochemistry (2012) 0.77
Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res (2014) 0.76
Gelsolin levels are increased in the brain as a function of age during normal development in children that are further increased in Down syndrome. Alzheimer Dis Assoc Disord (2009) 0.76
High-affinity rabbit monoclonal antibodies specific for amyloid peptides amyloid-β40 and amyloid-β42. J Alzheimers Dis (2011) 0.76
Binding of trypsin to fibrillar amyloid beta-protein. Brain Res (2006) 0.75